ORION-8 A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and elevated LDL-C

The purpose of the study is to evaluate the efficacy, safety and long tolerability of long-term dosing of inclisiran in patient with atherosclerotic cardiovascular disease, hypercholesterolemiaand elevated LDL-C (Bad Cholesterol)